A review of antibiotics in dermatology

Journal of Cutaneous Medicine and Surgery

Volumn 6, Issue 2, 2002, Pages 128-150

  Carrasco, Daniel A ^a   Vander Straten, Melody ^a   Tyring, Stephen K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BACTERIAL VACCINE; CEFAMANDOLE NAFATE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPSONE; DOXYCYCLINE; ERYTHROMYCIN; LINEZOLID; LYME DISEASE VACCINE; MACROLIDE; METRONIDAZOLE; MOXIFLOXACIN; OFLOXACIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; PENICILLIN V; PENICILLIN V POTASSIUM; PHENYTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG; WARFARIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; DIARRHEA; DRUG FEVER; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; FATIGUE; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEADACHE; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HUMAN; INFECTIOUS MONONUCLEOSIS; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NEUTROPENIA; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SKIN INFECTION;

ANTI-BACTERIAL AGENTS; HUMANS; SKIN DISEASES, BACTERIAL;

EID: 0036260308     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-001-0039-4     Document Type: Review

References (79)

1. Overview of antibiotics
2. Severe adverse cutaneous reactions to drugs
3. Fixed drug eruption. A brief review
4. Vasculitides associated with infections, immunizations, and antimicrobial drugs
5. Pemphigus and bullous pemphigoid due to drugs
6. Acute generalized exanthematous pustulosis. Analysis of 63 cases
7. A perspective on penicillin allergy
8. Penicillin hypersensitity - A review
9. Cephalosporins, carbapenems and monobactams
10. Treatment of late Lyme borreliosis-randomized comparison of ceftriaxone and penicillin
11. Immediate hypersensitivity reactions to beta-lactamantibiotics
12. Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim-sulfamethoxazole
13. The use of tetracycline for the treatment of sarcoidosis
14. Acne
15. The newer macrolides, azithromycin and clarithromycin
16. Clarithromycin: Review of a new macrolide antibiotic with improved microbiologic spectum and favorable pharmaco kinetic and adverse effect profiles
17. The new macrolides: Azithromycin and clarithromycin
18. Erythromycin in pityriasis rosea: A double blind, placebo-controlled clinical trial
19. Azithromycin and doxycycline for the treatment of Borreliaculture-positive erythema migrans
20. Clarithromycin in the treatment of early Lyme disease: A pilot study
21. Comparative studies of azithromycin in skin and soft tissue infections and sexually transmitted infections by Neisseria and Chlamydia species
22. Clarithromycin, a unique macrolide: A pharmacokinetic, microbiological and clinical overview
23. Azithromycin compared with cephalexin in the treatment of skin and skin structure infections
24. Multicenter trial of single-dose azithromycin vs ceftriaxone in the treatment of uncomplicated gonorrhea
25. 1,8-Naphthyridine derivatives: A new class of chemotherapy agents
26. Structure-activity relationship of the-fluoroquinolones
27. Structure-activity and structure-side effect relationships of the quinolone antibacterials
28. The fluoroquinolones
29. Fluoroquinolones
30. Clinical safety profile of newer fluoroquinolones
31. Prevention of recurrent staphylococcal skin infections with low-dose clindamycin therapy
32. Dermatologic manifestations of human immunodeficiency virus infection
33. Dietary constituents and rifampicin absorption
34. A comparative of efficacy of drug regimens in skin tuberculosis
35. Addition of rifampicin to conventional therapy for recurrent furunculosis
36. The effect of rifampicin on rhinoscleroma
37. Adverse effects of rifampin
38. The effect of antimicrobial agents on leukocytechemotaxis
39. Metronidazole
40. Overview of antibiotics
41. Overview of antibiotics
42. Oxazolidinones: A new class of antimicrobials
43. Piperazinyl oxazolidinones antibacterial agents containing apyridine, diazine or triazene hetero aromatic ring
44. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials
45. Comparative in vitro activities and postantibiotic effects ofthe oxazolidinones compounds eperezolid (PNU-100592) and linezolid(PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase negative staphylococci, Enterococcus faecalis, and Enterococcus faecium
46. In vitro activities of PNU 100592 and PNU 100766, noveloxazolidinones antibacterial agents
47. Linezolid (Zyvox)
48. Antibiotics for gram-positive bacterial infections
49. Quinupristin/dalfopristin (RP 59500): A new streptograminantibiotic
50. In vitro activity of quinupristin/dalfopristin, RP 59500, against gram positive clinical isolates
51. Topical antibacterial agents
52. Acne: An overview of clinical research findings
53. Topical antibiotics in dermatology
54. Effectiveness of mupirocin in the control of methicillin-resistant Staphylococcus aureus
55. Rifampin as antibiotic adjunct works well for recurrentboils
56. The staphylococci. Importance of their control in the management of skin disease
57. Infections and allergy incidence in ambulatory surgery patientsusing white petrolatum versus bacitracin ointment
58. Tetracycline, chloramphenicol, erythromycin, and miscellaneous antibacterial agents
59. Eczema of the lower leg and contact allergy
60. Allergy to various components of topical preparations in stasisdermatitis and leg ulcer
61. Otitis externa, otitis media, and mastoiditis
62. The aminoglycosides
63. Acute Pseudomonas infection of the external ear (malignant external otitis)
64. Biosynthesis of antimicrobial drugs
65. Chloramphenicol (topical)
66. Package insert for Furacin (nitrofurazone cream)
67. A review of topical agents for wounds and methods of wounding. Guidelines for wound management
68. Topical agents in burn and wound care
69. Prevention of recurrent staphylococcal skin infections with low-dose clindamycin therapy
70. Cutaneous abscesses: Anaerobic and aerobic bacteriology andoutpatient management
71. The treatment of acute superficial abscesses: A prospective clinical trial
72. Antibiotic prophylaxis in dermatologic surgery